These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 7925107)
1. Characterization of the effects of retinoic acid on vasoactive intestinal polypeptide gene expression in neuroblastoma cells. Georg B; Wulff BS; Fahrenkrug J Endocrinology; 1994 Oct; 135(4):1455-63. PubMed ID: 7925107 [TBL] [Abstract][Full Text] [Related]
2. Vasoactive intestinal peptide decreases MYCN expression and synergizes with retinoic acid in a human MYCN-amplified neuroblastoma cell line. Chevrier L; Meunier AC; Cochaud S; Muller JM; Chadéneau C Int J Oncol; 2008 Nov; 33(5):1081-9. PubMed ID: 18949372 [TBL] [Abstract][Full Text] [Related]
3. Cholinergic regulation of VIP gene expression in human neuroblastoma cells. Kristensen B; Georg B; Fahrenkrug J Brain Res; 1997 Nov; 775(1-2):99-106. PubMed ID: 9439833 [TBL] [Abstract][Full Text] [Related]
4. Autoregulation of neuroblastoma growth by vasoactive intestinal peptide. Pence JC; Shorter NA J Pediatr Surg; 1992 Aug; 27(8):935-43; discussion 944. PubMed ID: 1328588 [TBL] [Abstract][Full Text] [Related]
5. Cyclic AMP regulation of pro-vasoactive intestinal polypeptide/PHM-27 synthesis in human neuroblastoma cells. Hayakawa Y; Obata K; Itoh N; Yanaihara N; Okamoto H J Biol Chem; 1984 Jul; 259(14):9207-11. PubMed ID: 6086627 [TBL] [Abstract][Full Text] [Related]
6. Distinct regulation of vasoactive intestinal peptide (VIP) expression at mRNA and peptide levels in human neuroblastoma cells. Agoston DV; Colburn S; Krajniak KG; Waschek JA Neurosci Lett; 1992 May; 139(2):213-6. PubMed ID: 1319016 [TBL] [Abstract][Full Text] [Related]
7. Effect of thyroid hormones on vasoactive intestinal polypeptide gene expression in the rat cerebral cortex and anterior pituitary. Buhl T; Georg B; Nilsson C; Mikkelsen JD; Wulff BS; Fahrenkrug J Regul Pept; 1995 Feb; 55(3):237-51. PubMed ID: 7761623 [TBL] [Abstract][Full Text] [Related]
8. Retinoic acid enhances VIP receptor expression and responsiveness in human neuroblastoma cell, SH-SY5Y. Waschek JA; Muller JM; Duan DS; Sadée W FEBS Lett; 1989 Jul; 250(2):611-4. PubMed ID: 2546814 [TBL] [Abstract][Full Text] [Related]
9. Retinoic acid down-regulates the expression of the vasoactive intestinal polypeptide receptor type-1 in human breast carcinoma cell lines. Madsen B; Georg B; Vissing H; Fahrenkrug J Cancer Res; 1998 Nov; 58(21):4845-50. PubMed ID: 9809989 [TBL] [Abstract][Full Text] [Related]
10. Signaling pathways in PACAP regulation of VIP gene expression in human neuroblastoma cells. Falktoft B; Georg B; Fahrenkrug J Neuropeptides; 2009 Oct; 43(5):387-96. PubMed ID: 19712974 [TBL] [Abstract][Full Text] [Related]
11. Location of PHM/VIP mRNA in human gastrointestinal tract detected by in situ hybridization. Bredkjaer HE; Wulff BS; Emson PC; Fahrenkrug J Cell Tissue Res; 1994 May; 276(2):229-38. PubMed ID: 8020060 [TBL] [Abstract][Full Text] [Related]
12. Suppression of tumorigenicity in neuroblastoma cells by upregulation of human vasoactive intestinal peptide receptor type 1. Balster DA; O'Dorisio MS; Albers AR; Park SK; Qualman SJ Regul Pept; 2002 Nov; 109(1-3):155-65. PubMed ID: 12409228 [TBL] [Abstract][Full Text] [Related]
13. Expression of messenger ribonucleic acids encoding neuropeptide-Y, substance-P, and vasoactive intestinal polypeptide in human pituitary. Byrne JM; Jones PM; Hill SF; Bennet WM; Ghatei MA; Bloom SR J Clin Endocrinol Metab; 1992 Oct; 75(4):983-7. PubMed ID: 1383256 [TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal peptide: a growth promoter in neuroblastoma cells. Wollman Y; Lilling G; Goldstein MN; Fridkin M; Gozes I Brain Res; 1993 Oct; 624(1-2):339-41. PubMed ID: 8252411 [TBL] [Abstract][Full Text] [Related]
15. All prepro-VIP-derived peptides, except PHI/PHV, are expressed in the female rat anterior pituitary and increased by estrogen. Skakkebaek ML; Georg B; Mikkelsen JD; Ottesen B; Fahrenkrug J Peptides; 1995; 16(7):1287-94. PubMed ID: 8545253 [TBL] [Abstract][Full Text] [Related]
16. Regulation of retinoic acid receptor alpha expression in human neuroblastoma cell lines and tumor tissue. Marshall GM; Cheung B; Stacey KP; Norris MD; Haber M Anticancer Res; 1994; 14(2A):437-41. PubMed ID: 8017844 [TBL] [Abstract][Full Text] [Related]
17. Peptide contents of neuropeptide Y, vasoactive intestinal polypeptide, and beta-calcitonin gene-related peptide and their messenger ribonucleic acids after dexamethasone treatment in the isolated rat islets of Langerhans. Jamal H; Jones PM; Byrne J; Suda K; Ghatei MA; Kanse SM; Bloom SR Endocrinology; 1991 Dec; 129(6):3372-80. PubMed ID: 1954911 [TBL] [Abstract][Full Text] [Related]
18. Characterization and regional distribution of peptides derived from the vasoactive intestinal peptide precursor in the normal human brain. Fahrenkrug J; Emson PC J Neurochem; 1989 Oct; 53(4):1142-8. PubMed ID: 2769258 [TBL] [Abstract][Full Text] [Related]
19. Induction of transforming growth factor beta 1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines. Cohen PS; Letterio JJ; Gaetano C; Chan J; Matsumoto K; Sporn MB; Thiele CJ Cancer Res; 1995 Jun; 55(11):2380-6. PubMed ID: 7757990 [TBL] [Abstract][Full Text] [Related]
20. Synergy of activin and ciliary neurotrophic factor signaling pathways in the induction of vasoactive intestinal peptide gene expression. Symes AJ; Pitts RL; Conover J; Kos K; Coulombe J Mol Endocrinol; 2000 Mar; 14(3):429-39. PubMed ID: 10707960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]